1. Refractory SLE patients respond to the proteasome inhibitor bortezomib. (22nd February 2012) Authors: Hiepe, F; Alexander, T; Peukert, R; Rubbert, A; Rech, J; Braun, T; Schott, G; Wiesener, M; Eckardt, K U; Baeuerle, M; Reisch, A; Hoyer, B; Taddeo, A; Burmester, G; Schett, G; Radbruch, A; Voll, R E Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗